Yale BioHaven Entrepreneurship Seminars: "HistoRx — Medical Diagnostics for 21st Century"
The Yale BioHaven Entrepreneurship Seminars series continues on Wednesday, February 8 from 4 to 5 p.m. in the Anlyan Center Auditorium of Yale Medical School, 300 Cedar Street.
This seminar will feature HistoRx, a local technology start-up company that is introducing a new generation of advanced quantitative diagnostic products for research and clinical pathology markets. The products are based on the company’s proprietary integrated tissue analysis platform, AQUA™, a technology pioneered at the Yale University School of Medicine.
Speakers are Robert A. Curtis, president and CEO of HistoRx and David A. Rimm, M.D., associate professor of pathology at Yale and Director of the Yale Cancer Center Tissue Microarray Facility. Rimm is a developer of the AQUA™ technology.
HistoRx, located in the technology incubator at 300 George Street in New Haven, was founded in August 2004. The company closed on a $2-million Series A round of financing led by Navigator Technology Ventures (Draper Laboratories). Additional investors include Genentech, Sachem Ventures, and a group of private investors.
Curtis and Rimm will tell how they put the right technology together with the right people at the right time. Their intention is to motivate new academic founders and entrepreneurs to see that their ideas and business plans can be realized.
The seminar will be followed by refreshments and networking. Registration is free, but required, by contacting Lucy Sargeant at firstname.lastname@example.org or calling the Yale Office of Cooperative Research directly at 203-436-8096
Yale BioHaven Entrepreneurship Seminars are sponsored jointly by the Yale Office of Cooperative Research and Connecticut United for Research Excellence (CURE), Yale Entrepreneurial Society (YES), and Yale Biotechnology & Pharmaceutical Society (YBPS). For further information on the seminar, please contact Catherine S. Koh.
VaxInnate will be featured in the next seminar of the series; Ruslan Medzhitov and Jeff Powell will present their case study on Tuesday, March 14.